News

News
Partner news

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
Partner news

Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.

Read full story
Partner news

Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools

Read full story
Partner news

Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.

Read full story
Partner news

World-leading genomics project to give insights into health and disease - In a major advance for public health, a £200m project involving the government, charity and four leading pharmaceutical companies was announced today

Read full story
Partner news

DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions

Read full story
Partner news

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story
Partner news

Cala Health Raises $50 Million Series C Funding

Read full story
Partner news

TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform

Read full story
Partner news

Zebra Medical Vision Receives FDA Approval for World's First AI Chest X-ray Triage Product

Read full story
Partner news

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story
Partner news

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story
Partner news

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story
Partner news

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

Read full story